HOPE Therapeutics, Inc., (“HOPE,” the “Company”), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, Inc. (“NRx”) (Nasdaq: NRXP), announces signing of a definitive Agreement to acquire Dura Medical (Dura), per the previously announced non-binding Letter of Intent. Dura, together with the previously announced Neurospa network, are anticipated to provide a comprehensive service offering to patients on Florida’s west coast. Dura is revenue generating and EBITDA positive. Dura Medical was founded in 2018 to offer a gold-standard, precision approach to treating mental health and chronic pain on the west coast of Florida.
Read the full article: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical //
Source: https://www.prnewswire.com/news-releases/hope-therapeutics-inc-and-nrx-pharmaceuticals-inc-nasdaqnrxp-announce-definitive-purchase-agreement-with-dura-medical-initial-acquisition-for-planned-international-network-of-interventional-psychiatry-clinics-302415522.html